Drug Shortage Report for OCTREOTIDE FOR INJECTABLE SUSPENSION
| Report ID | 166969 |
| Drug Identification Number | 02503751 |
| Brand name | OCTREOTIDE FOR INJECTABLE SUSPENSION |
| Common or Proper name | OCTREOTIDE FOR INJ |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | OCTREOTIDE |
| Strength(s) | 10MG |
| Dosage form(s) | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 1 |
| ATC code | H01CB |
| ATC description | HYPOTHALAMIC HORMONES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-08-18 |
| Estimated end date | 2024-06-10 |
| Actual end date | 2024-06-14 |
| Shortage status | Resolved |
| Updated date | 2024-06-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v26 | 2024-06-17 | French | Compare |
| v25 | 2024-06-17 | English | Compare |
| v24 | 2024-06-17 | French | Compare |
| v23 | 2024-06-17 | English | Compare |
| v22 | 2024-06-13 | French | Compare |
| v21 | 2024-06-13 | French | Compare |
| v20 | 2024-06-13 | English | Compare |
| v19 | 2024-05-16 | French | Compare |
| v18 | 2024-05-16 | English | Compare |
| v17 | 2024-05-14 | French | Compare |
| v16 | 2024-05-14 | English | Compare |
| v15 | 2024-04-29 | French | Compare |
| v14 | 2024-04-29 | English | Compare |
| v13 | 2024-02-22 | French | Compare |
| v12 | 2024-02-22 | English | Compare |
| v11 | 2023-04-24 | French | Compare |
| v10 | 2023-04-24 | English | Compare |
| v9 | 2023-02-02 | French | Compare |
| v8 | 2023-02-02 | English | Compare |
| v7 | 2022-09-22 | French | Compare |